CorMedix
CRMD
56 hedge funds and large institutions have $41.3M invested in CorMedix in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 4 closing their positions.
323% more capital inflows, than outflows
Capital inflows: $11.5M | Capital outflows: $2.72M
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
19% more funds holding
Funds holding: 47 → 56 (+9)
3.06% more ownership
Funds ownership: 22.78% → 25.84% (+3.1%)
79% less call options, than puts
Call options by funds: $462K | Put options by funds: $2.18M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.09M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.93M |
| 3 |
BlackRock
New York
|
+$1.75M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.75M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$748K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
-$883K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$632K |
| 3 |
Franklin Resources
San Mateo,
California
|
-$319K |
| 4 |
Millennium Management
New York
|
-$288K |
| 5 |
Goldman Sachs
New York
|
-$251K |
CRMD Hedge Fund Activity: Q3 2019 in Review
56 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2019, worth a combined $41.3M — down 15% from $48.6M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CRMD positions and 4 closed out — a net gain of 9 holders — while 17 added to existing stakes and 13 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $2.09M. The largest seller was Nuveen, cutting an estimated $883K.
- 56 institutional investors held CorMedix (CRMD) as of Q3 2019, up from 47 in Q2 2019.
- Funds reported $41.3M of CorMedix stock for Q3 2019, down 15% quarter-over-quarter.
- 13 funds opened new CorMedix positions in Q3 2019 and 4 closed out, a net change of +9 holders.
- The largest CorMedix buyer in Q3 2019 was Sabby Management, an estimated $2.09M added.
- The largest CorMedix seller in Q3 2019 was Nuveen, an estimated $883K sold.
Based on aggregated 13F filings for Q3 2019.